Health Care: Drugs

Mylan NV (MYL: NASDAQ)

$42.85 -0.3 | -0.7%
08/25/16 - 04:00 PM ET
Company Income Statement
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Sales 9.43B 7.72B 6.91B 6.80B
Cost of Sales 4.18B 3.62B 3.35B 3.34B
Gross Operating Profit 5.25B 4.09B 3.56B 3.45B
Selling, General, and Administrative Expenses 2.18B 1.63B 1.41B 1.40B
Research & Development 671.90M 581.80M 507.82M 401.34M
Operating Income before D & A (EBITDA) 2.40B 1.89B 1.64B 1.65B
Depreciation & Amortization 1.03B 566.60M 516.00M 546.60M
Interest Income 0.00 0.00 0.00 0.00
Other Income - Net -206.10M -44.90M -74.85M 6.56M
Special Income / Charges 97.40M 32.10M 14.64M 0.00
Total Income Before Interest Expenses (EBIT) 1.25B 1.31B 1.06B 1.11B
Interest Expense 339.40M 333.20M 313.34M 308.70M
Pre-Tax Income 915.40M 974.50M 747.34M 804.08M
Income Taxes 67.70M 41.40M 120.81M 161.15M
Minority Interest 100.00K 3.70M 2.82M 2.08M
Net Income From Continuing Operations 847.70M 933.10M 626.53M 642.93M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 847.70M 933.10M 626.53M 642.93M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 847.60M 929.40M 623.71M 640.85M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
750.30M 901.00M 611.89M 642.93M
Preferred Dividends
Net Income Available To Common 847.70M 933.10M 626.53M 642.93M
Basic EPS from Continuing Ops. 1.80 2.49 1.63 1.54
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 1.80 2.49 1.63 1.54
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 1.80 2.49 1.63 1.54
Basic Normalized Net Income/Share 1.59 2.40 1.59 1.54
EPS fr Continuing Ops. 1.70 2.34 1.58 1.52
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 1.70 2.34 1.58 1.52
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 1.70 2.34 1.58 1.52
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
1.51 2.25 1.54 1.52
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with MYL

Latest MYL Headlines from TheStreet

More Financial News for MYL

Press Releases for MYL

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter